Chempartner Pharmatech Set to Add Two Major Shareholders to Roster
Chempartner Pharmatech (SHE:300149) said Liang Yufeng and Yu Xianwen are set to become major shareholders in the pharmaceutical company after Hangzhou Ciyangliangjia Investment Management Partnership transfers its holdings in the company.
Ciyangliangjia Investment Management Partnership holds 51,185,660 shares of the company, or a 10.24% stake, according to a Thursday filing with the Shenzhen bourse.
Following the share transfer, Liang will hold a 5.24% stake and Yu will hold a 5.00% stake in Chempartner Pharmatech.
Price (RMB): ¥4.64, Change: ¥-0.020, Percent Change: -0.43%
免责声明:投资有风险,本文并非投资建议,以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请,作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考,不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证,投资者应自行研究并在投资前寻求专业建议。